| Application no. and date | 20206423.4 (espacenet) (Federated) (European Patent Register), 20110325 | | Patent/reg. no. and date | DK/EP 3835297, 20230607 | | Publication date | 20210616 | | Priority no. and date | US 31737610 P, 20100325, US 31995310 P, 20100401, US 32163610 P, 20100407, US 32156110 P, 20100407 | | EP pub. no. and date |
EP 3835297 20210616 | | Effective date | | | Applicant/owner | Vertex Pharmaceuticals Incorporated, 50 Northern Avenue
Boston, MA 02210, US | | Applicant ref. no. | | | Inventor | KRAWIEC, Mariusz, 46 Littlefield Lane
Marlborough, MA 01752, US,
ZHANG, Yuegang, 15 Fairfield Road
Wayland, MA 01778, US,
ZHANG, Beili, 4505 Shorepointe Way
San Diego, CA 92130, US,
KESHAVARZ-SHOKRI, Ali, 4285 Corte Langostino
San Diego, CA 92130, US,
ALCACIO, Tim Edward, 50 Northern Avenue
Boston, MA 02210, US,
LEE, Elaine Chungmin, 50 Northern Avenue
Boston, MA 02210, US | | Representative | | | Opponent | | | IPC Class | C07D 405/12 (2006.01) | | Title | SYNTHESIS AND INTERMEDIATES OF (R)-1(2,2 -DIFLUOROBENZO[D][1,3]DIOXOL-5YL)-N-(1-(2,3-DIHYDROXYPROPYL)-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2YL)-1H-INDOL-5YL)CYCLOPROPANECARBOXAMIDE | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
